Alterations in homologous recombination repair genes in prostate
Descrição
ASCO GU 2020: Contemporary Clinical Impact of Genetic and Genomic Testing in Prostate Cancer
Role of the DNA damage response in prostate cancer formation, progression and treatment
Prostate cancer
Molecular Genetics of Prostate Cancer and Role of Genomic Testing - Surgical Pathology Clinics
The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies - Rimar - 2017 - Cancer - Wiley Online Library
High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer –Results from a prospective pilot study using a 37 gene panel - ScienceDirect
Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination
PDF) Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
IJMS, Free Full-Text
Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer
GenPath Oncology - The NCCN guidelines for prostate cancer recommend the evaluation of alterations in homologous recombination (HR) DNA repair genes such as BRCA1, BRCA 2, ATM, PALB2, FANCA, RAD51D, CHEK2, and
Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer: Trends in Molecular Medicine
Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer
When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancers: Trends in Cancer
DNA double-strand break repair by homologous recombination. Coordinated
de
por adulto (o preço varia de acordo com o tamanho do grupo)
